- 全部删除
您的购物车当前为空
Perifosine (KRX-0401) 是一种具有口服活性的烷基磷酸胆碱 Akt 抑制剂,具有抗肿瘤活性。


为众多的药物研发团队赋能,
让新药发现更简单!
Perifosine (KRX-0401) 是一种具有口服活性的烷基磷酸胆碱 Akt 抑制剂,具有抗肿瘤活性。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 369 | In stock | |
| 2 mg | ¥ 529 | In stock | |
| 5 mg | ¥ 897 | In stock | |
| 10 mg | ¥ 1,630 | In stock | |
| 25 mg | ¥ 2,720 | In stock | |
| 50 mg | ¥ 3,970 | In stock | |
| 100 mg | ¥ 5,780 | In stock |
Perifosine 相关产品
| 产品描述 | Perifosine (KRX-0401) is an oral-active, alkyl-phosphocholine Akt inhibitor with potential antineoplastic activity. |
| 靶点活性 | Akt:4.7 μM |
| 体外活性 | 在神经胶质瘤中,Perifosine激活Akt和Ras-ERK1/2途径.Perifosine诱导血小板和白细胞增多,导致移植骨髓瘤的凋亡. |
| 体内活性 | 在MM.1S细胞中,Perifosine(10 μM )能够完全抑制Akt的磷酸化。在永生化角质形成细胞和头颈部鳞状癌细胞中(IC50=0.6-8.9 μM),Perifosine抑制细胞增殖。在小鼠的神经胶质祖细胞中,Perifosine通过减少Akt的磷酸化水平和细胞外信号调节激酶,诱导细胞周期停滞在G1和G2,引起细胞生长抑制。在人类肝癌细胞中,Perifosine通过阻断Akt的磷酸化,诱导细胞周期停滞和细胞凋亡。 |
| 激酶实验 | Akt kinase assay: MM.1S cells are cultured in the presence or absence of perifosine (5 μM, 6 hours) and then stimulated with IL-6 (20 ng/mL, 10 minutes). In vitro akt kinase assay is then carried out using the Akt Kinase Assay Kit. |
| 细胞实验 | Cells are incubated in the medium with 10% FCS for 48 hours with indicated concentration of Periosine. Cell viability is determined by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. (Cell Proliferation Kit I; Roche). The absorbance at 590 nm is recorded using the 96-well plate reader.(Only for Reference) |
| 别名 | 哌立福新, NSC 639966, KRX-0401, D21266 |
| 分子量 | 461.66 |
| 分子式 | C25H52NO4P |
| CAS No. | 157716-52-4 |
| Smiles | O(P(OCCCCCCCCCCCCCCCCCC)(=O)[O-])C1CC[N+](C)(C)CC1 |
| 密度 | no data available |
| 颜色 | White |
| 物理性状 | Solid |
| 存储 | keep away from moisture,store at low temperature,store under nitrogen | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||
| 溶解度信息 | DMSO: Insoluble H2O: 10 mM, Sonication is recommended. | ||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||
H2O
| |||||||||||||||||||||
评论内容